Omeros | OMER - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Adma Biologics USD 57.13M 4.47M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -11.37M 150.72M 2026-06
Knight Therapeutics CAD -1.92M 13.69M 2025-09
MacroGenics USD -36.77M 21.84M 2026-03
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 5M 4.43M 2026-03
Pfizer USD -653M 5.84B 2026-06
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06